BP+ and Mount Everest Hypertension Study
Uscom announced the publication of a study of 90 British servicemen and women and the effects on their central blood pressure (cBP) using the Uscom BP+ as they ascended from near sea level to a maximum of 5,360m over a period of 14 days in the Dhaulagiri region in the Himalayas at the base of Mount Everest. The study found that systolic cBP measured by the Uscom BP+ was more sensitive than conventional systolic brachial (arm) BP for detecting the progressive BP changes of high altitude.